Learn more about Impella for Protected PCI

Protected PCI, or protected stenting, is a proven and widely accepted procedure using Impella, the world’s smallest heart pump, to temporarily assist the pumping function of the heart. Impella may enable placement of a stent for patients who are at high-risk for complications or have severe heart disease.

Learn more about Impella for Cardiogenic Shock

Cardiogenic shock is a life-threatening situation that occurs when the heart is unable to function properly, depriving critical organs of the blood they need to function. This may happen due to a sudden cardiac event such as a heart attack. When cardiogenic shock occurs, blood pressure becomes very low, signifying the heart’s inability to adequately pump blood in order to provide much-needed oxygen to vital organs. The Impella heart pump maintains blood flow to critical organs, allowing the physician to treat the underlying clinical issue.

Recovering Hearts. Saving Lives.

• Non-Surgical

  • A minimally invasive option for qualified patients with severe heart disease, including patients who are too high-risk for surgery
  • Avoids ‘chest cracking’ and open-heart surgery
  • Temporarily assists the pumping function of the heart, enabling it to rest and recover

• Safe and Effective

  • Proven safe & effective with more than 100,000 patients treated
  • Non-surgical procedure that avoids complications of open-heart surgery
  • Lower complication rate than other options¹

• Improved Quality of Life

  • 8-in-10 patients experience improved quality of life^{2, 3}
  • May reduce heart failure symptoms (fatigue, shortness of breath, swelling, coughing)³
  • Enables fewer days in the hospital^{4, 5, 6, 7}

The Impella Heart Pump is indicated for use in Protected PCI procedures and for patients undergoing treatment for most types of cardiogenic shock.

Important safety information.

The Impella 2.5® and Impella CP®, the World’s Smallest Heart Pumps, and are intended for temporary (six hours or less) use to maintain stable heart function. The Impella 2.5 and Impella CP can potentially lower certain risks in patients with severe coronary artery disease and diminished (but stable) heart function who are undergoing a percutaneous coronary intervention (PCI) such as an angioplasty or stenting, but are not candidates for surgery, as determined by a team of doctors that includes a heart surgeon.

Important Risk Information for the Impella 2.5 and Impella CP Devices

Protected PCI is not right for everyone. You should NOT be treated with the Impella 2.5 or Impella CP if your doctor determines you have certain pre-existing conditions, such as: Severe narrowing of your heart valves; Clots in your blood vessels; Replacement heart valve or; Certain deficiencies in your heart valve. Many of the risks related to the Impella 2.5 and Impella CP devices are the same as those with the procedure being completed and the placement of any pump used to help the heart. Risks related to use of the Impella 2.5 and Impella CP can include certain allergic reactions to medications, infections, blood clots, injury to heart tissue, valves or blood vessels, bleeding, low blood pressure, low platelet count and/or damage to red blood cells. Some of these conditions could be life threatening.